Prot #WTX‐330x2101: A Phase 1 (First‐In‐Human [FIH]), Multi‐Site, Dose Escalation and Expansion Study of WTX‐330 in Adult Patients with Advanced or Metastatic Solid Tumors or Lymphoma

Project: Research project

Project Details

StatusActive
Effective start/end date5/1/235/1/26

Funding

  • Clinipace, Inc. (Prot #WTX-330x2101 // Prot #WTX-330x2101)
  • Werewolf Therapeutics, Inc. (Prot #WTX-330x2101 // Prot #WTX-330x2101)